Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover trial of aclidinium bromide versus placebo and tiotropium in COPD
2005-005804-17Phase 3Completed
- Sponsor
- Almirall
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aclidinium in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Almirall. Primary endpoint: Rate of onset of bronchodilator action. Started Nov 2006; status: completed.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-005804-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005804-17.